GlassScriptPhysician profile
Devan Elizabeth Costelle
NPI 1962055319
$12,274.78
in general payments reported to CMS, 2019-2025
32 companies · $1,479 in 2025
The $1,479 reported for 2025 was more than what 90% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $133 · 2022: $1,412 · 2023: $5,831 · 2024: $3,419 · 2025: $1,479.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,888 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,063 · Travel and Lodging: $2,778.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,888.18 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,063.00 |
| Travel and Lodging | $2,778.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $9,533.98 | 2021-2025 | Hvad Pump Implant Kit, Aurora Ev-Icd Mri Surescan, Corevalve Evolut R |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $891.41 | 2021-2025 | Lifevest |
| Alnylam Pharmaceuticals INC. | $314.56 | 2023-2025 | Onpattro |
| Actelion Pharmaceuticals US, INC. | $265.00 | 2023-2025 | Uptravi, Opsumit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $175.81 | 2022-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $121.47 | 2022-2025 | |
| Kestra Medical Technology Services, INC. | $115.68 | 2024 | Assure Wcd |
| Merck Sharp & Dohme LLC | $81.85 | 2023-2025 | Verquvo, Winrevair |
| Kci USA, INC. | $78.20 | 2023 | V.A.C. Veraflo Cleanse Choice, Prevena |
| Abbott Laboratories | $62.04 | 2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Atricure, INC. | $52.30 | 2021-2022 | |
| Edwards Lifesciences Corporation | $46.41 | 2021-2025 | Mitris Resilia Mitral Valve |
| Baxter Healthcare | $45.32 | 2024-2025 | Preveleak, Perclot |
| Bridgebio Pharma, INC. | $39.25 | 2025 | Attruby |
| Cvrx, INC. | $39.05 | 2024-2025 | Barostim Neo System |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $35.65 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Lexicon Pharmaceuticals, INC. | $34.70 | 2023-2024 | Inpefa |
| Abiomed | $34.62 | 2025 | |
| Getinge USA Sales, LLC | $31.79 | 2021 | |
| Smith+Nephew, INC. | $29.96 | 2022-2025 | Renasys Touch, Pico 7 |
| Convatec INC. | $29.31 | 2022 | |
| Blue Surgical LLC | $28.25 | 2025 | |
| Teleflex LLC | $25.67 | 2023 | Quikclot |
| Werfen USA LLC | $23.44 | 2021 | |
| Csl Behring | $21.80 | 2023 | Kcentra |
| Cerus Corporation | $20.77 | 2023 | Intercept Blood System For Platelets |
| Solventum Corporation | $19.79 | 2025 | V.A.C. Veraflo, Prevena |
| Janssen Pharmaceuticals, INC | $17.13 | 2024 | Xarelto |
| United Therapeutics Corporation | $16.29 | 2024 | Remodulin, Orenitram |
| Corcym INC | $16.23 | 2024 | Perceval |
| Biomerieux INC | $14.00 | 2024 | Vidas Nephrocheck |
| Ambu INC. | $13.05 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devan Costelle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.